Characterization of upper lamina propria interstitial cells in bladders from patients with neurogenic detrusor overactivity and bladder pain syndrome.
The upper lamina propria (ULP) area of interstitial cells (IC) in bladder has been studied for more than a decade in several species including human beings. Nevertheless there is still lack of uniformity in terminology of this cell layer. The aim of the present study was to add new data to the morphological and immunohistochemical phenotype of these cells and to find out whether this phenotype is changed in bladders from patients with neurogenic detrusor overactivity (NDO) and bladder pain syndrome (BPS). Bladder tissue was obtained from a control group and from patients with NDO and BPS. Samples were processed for morphology, electron microscopy and immunohistochemistry. A morphological and immunohistochemical phenotype for the ULP IC was assessed and changes in this phenotype were looked for in samples from patients with NDO and BPS. The ULP IC were characterized ultrastructurally by the presence of actin filaments with densifications, many caveolae and abundant rough endoplasmic reticulum (RER); on immunohistochemistry ULP IC were immunoreactive for α-sma, vimentin, CD10 and podoplanin and categorized as interstitial Cajal-like cells (ICLC). In NDO and BPS bladders we found a phenotypical shift towards a fibroblastic phenotype which was even more pronounced in the NDO group. In both groups there was also an increased presence in ULP lymphocytes. The ULP area in the human bladder contains a population of ICLC with distinct ultrastructural morphology and immunohistochemical phenotype. Their unique α-sma(+) /desmin(-) /CD34(-)  phenotype allows studying this population in various bladder disorders. In bladders form patients with BPS and NDO, we observed these ULP ICLC to shift towards a fibroblast phenotype.
KU Leuven, Department of Morphology and Molecular Pathology, Leuven, Belgium. Thomas.Gevaert@uz.kuleuven.ac.be
Thomas
T
Gevaert
Rita
R
De Vos
Wouter
W
Everaerts
Louis
L
Libbrecht
Frank
F
Van Der Aa
Joost
J
van den Oord
Tania
T
Roskams
Dirk
D
De Ridder
D000328:Adult; D018856:Cystitis, Interstitial / Q000473:pathology*; D005260:Female; D006801:Humans; D056885:Interstitial Cells of Cajal / Q000473:pathology* / Q000648:ultrastructure; D008297:Male; D008875:Middle Aged; D009092:Mucous Membrane / Q000473:pathology* / Q000648:ultrastructure; D010641:Phenotype; D001743:Urinary Bladder / Q000166:cytology* / Q000648:ultrastructure; D001750:Urinary Bladder, Neurogenic / Q000473:pathology*; D053201:Urinary Bladder, Overactive / Q000473:pathology*
BJU Int. 2003 Jan;91(1):89-93
12614258
Hum Pathol. 2002 Aug;33(8):806-11
12203213
Virchows Arch. 2002 Jun;440(6):589-93
12070597
Urology. 2001 Feb;57(2):239-45
11182328
J Cell Mol Med. 2008 Jan-Feb;12(1):22-37
18182061
J Urol. 2005 Apr;173(4):1385-90
15758810
J Urol. 2004 Jun;171(6 Pt 1):2492-6
15126883
J Urol. 2010 Jul;184(1):370-7
20488490
Eur Urol. 2009 Sep;56(3):427-9
19342152
Lancet. 2001 Aug 4;358(9279):401-3
11502339
Urology. 1997 Dec;50(6A Suppl):36-52; discussion 53-6
9426749
Cell Tissue Res. 2009 Mar;335(3):517-27
19142665
Histopathology. 2009 Oct;55(4):423-31
19817893
J Cell Mol Med. 2005 Jul-Sep;9(3):543-56
16202204
J Cell Mol Med. 2010 Apr;14(4):729-40
20367664
Eur Urol. 2007 Oct;52(4):1213-21
17292535
J Cell Mol Med. 2008 Oct;12(5B):1944-55
19145703
BJU Int. 2006 Jan;97(1):29-32
16336323
Br J Urol. 1994 May;73(5):508-15
8012772
Neurourol Urodyn. 2008;27(4):264-73
17849480
Int J Cancer. 2008 Sep 1;123(5):1053-9
18546264
Neurourol Urodyn. 2007 Oct;26(6 Suppl):914-9
17763395
BJOG. 2004 Dec 1;111(s1):57-60
15663383
Cell Tissue Res. 2005 Sep;321(3):341-51
15965654
J Clin Pathol. 1998 Mar;51(3):211-4
9659262
Oncology. 2009;77(1):53-62
19556810
Neurourol Urodyn. 2010;29(1):82-7
20025023
Urology. 2004 Oct;64(4):809-13
15491739